Current news reports (September 23/24, 2015) are pointing an accusing finger at a pharmaceutical company’s CEO for suddenly increasing the price of a medicine it manufactures and sells–from about $15 per pill to about $700 per pill. (The details vary, of course, because what price is charged can depend on the retailer.) Apparently, from reports I have seen on network news and read, this medicine has no competition; there is no generic or less expensive version or viable alternative. So,... Read more